1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

23 Mar 2021
Admin
News Article

Patanjalis Coronil Has No Regulatory Approvals IMA

The Indian Medical Association (IMA) has stated that the Central Drugs Standard Control Organisation (CDSCO) has not given permission for the use of Patanjali’s Coronil for the treatment of Covid-19.The IMA’s statement is based on a response it received from the CDSCO against a Right to Information (RTI) application filed by the Association.The IMA added that it had raised questions on the usage of certain tablets (Coronil) as a curative medicine for the Corona infection, when it was promoted as preventive and curative medicine by the producers of the drug.“The claim as the evidenced-based drug was also questioned as the evidence cited was just a Pilot study with 45 asymptomatic patients. It was also falsely promoted as the CDSCO has given license for the drug to be used as a therapeutic drug,” the IMA stated.As for WHO certification, which is Certification of Pharmaceutical Product (CoPP), the national regulatory authority issues it for the purpose of international commerce i.e. for registration of product in foreign countries, the IMA further stated.In a letter to IMA, Sushanta Sarkar, Assistant Drugs Controller (India) said, “CDSCO has issued Certification of pharmaceutical product to Divya Pharmacy Unit (II), Haridwar for their product Divya coronil tablet, after examination of their application in consultation with the Ministry of Ayush.”“IMA acknowledges and respects the valuable contribution of pure Ayurveda drugs and their role in building immunity which will help the overall well-being. But using it as an only curative drug for infected people will be a dangerous one. In the pandemic we need to be extra cautious as any false hope will enhance the spread of the disease,” the association stated.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!